658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC)
Matt D. Galsky, Xin‐Yuan Guan, Romain Banchereau, L. Wang, Jun Zhu, Haocheng Yu, Deepali Rishipathak, Emma Hajaj, R. Herbst, Ian D. Davis, Enrique Grande, Aristotelis Bamias, Maria De Santis, José Ángel Arranz, Eiji Kikuchi, J. Zhang, C. Lee, Xixi Shen, Peter C. Black, Sanjeev Mariathasan
Topics & Concepts
AtezolizumabMedicineCarboplatinCisplatinOncologyUrothelial cancerChemotherapyInternal medicineCancerCancer researchBladder cancerImmunotherapyNivolumabBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersImmune cells in cancer